Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales

INTRODUCTION: Carbapenems (CR) have traditionally been the first line treatment for bacteremia caused by AmpC-producing Enterobacterales. However, CR have a high ecological impact, and carbapenem-resistant strains continue rising. Thus, other treatment alternatives like Piperacillin-Tazobactam (P-T)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ávila-Núñez, M., Lima, O., Sousa, A., Represa, M., Rubiñán, P., Celestino, P., Garrido-Ventín, M., García-Formoso, L., Vasallo-Vidal, F., Martinez-Lamas, L., Pérez-Landeiro, A., Rubianes, M, Pérez-Rodríguez, MT.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436381/
https://www.ncbi.nlm.nih.gov/pubmed/37592268
http://dx.doi.org/10.1186/s12941-023-00624-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436381/
https://www.ncbi.nlm.nih.gov/pubmed/37592268
http://dx.doi.org/10.1186/s12941-023-00624-9

Ejemplares similares